| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/1997 | US5625049 Nucleic acids encoding human astrovirus serotype 2 |
| 04/29/1997 | US5625048 Modified green fluorescent proteins |
| 04/29/1997 | US5625041 Purification of proteins |
| 04/29/1997 | US5625040 Phosphacan: a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell adhesion molecules |
| 04/29/1997 | US5625036 Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids |
| 04/29/1997 | US5625035 Erythropoietin binding protein from mammalian serum |
| 04/29/1997 | US5625034 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/29/1997 | US5625033 Heterofunctinal binding fusion proteins |
| 04/29/1997 | US5625032 Selective amylin antagonist peptides and uses therefor |
| 04/29/1997 | US5625031 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein |
| 04/29/1997 | US5624905 Merosin fragments and uses thereof |
| 04/29/1997 | US5624904 Method for treating gram positive septicemia |
| 04/29/1997 | US5624903 Phosphoinositol-glycan-peptide with insulin-like action |
| 04/29/1997 | US5624900 High binding activity for human interleukin-1; treating rheumatoid arthritis |
| 04/29/1997 | US5624899 Ligands and proteins |
| 04/29/1997 | US5624894 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 04/29/1997 | US5624837 Nucleic acid encoding chimeric complement inhibitor proteins |
| 04/29/1997 | US5624832 β1 6 N-acetylglucosaminyltransferase, its acceptor molecule, leukosialin, and a method for cloning proteins having enzymatic activity |
| 04/29/1997 | US5624827 DNA sequences encoding the plant toxin gelonin |
| 04/29/1997 | US5624826 Cloning vector plasmid vector-primer derived therefrom and preparation method of the same |
| 04/29/1997 | US5624823 DNA encoding procine interleukin-10 |
| 04/29/1997 | US5624822 Hirudin fusion proteins and preparation of hirudin |
| 04/29/1997 | US5624821 Antibodies with altered effector functions |
| 04/29/1997 | US5624820 Episomal expression vector for human gene therapy |
| 04/29/1997 | US5624819 Dna, nucleic acid detectors, mutant genes and genetic engineering |
| 04/29/1997 | US5624818 Genetic engineering, hybridization and dna sequences |
| 04/29/1997 | US5624817 Mutations in the gene encoding the alpha chain of platelet glycoprotein Ib |
| 04/29/1997 | US5624816 Transmembrane glycoprotein ASGP-2: nucleotide sequences and recombinant production of proteins |
| 04/29/1997 | US5624806 Antibodies to cardiac hypertrophy factor and uses thereof |
| 04/29/1997 | US5624805 Measuring the level of unbound somatomedins in human fluids |
| 04/29/1997 | US5624804 Glycosylation of protein such as albumin for medical diagnosis |
| 04/29/1997 | US5624801 Methods of identifying human osteoclast-specific and related genes |
| 04/29/1997 | US5624799 Cancer-associated mar binding protein |
| 04/29/1997 | US5624795 Isolation and characterization of a novel chimpanzee lentivirus, designated simian immunodeficiency virus isolate cpz-ant |
| 04/28/1997 | CA2188900A1 Gene of the hop latent virus and methods for detecting the same |
| 04/28/1997 | CA2185407A1 Sustainable chick cell line infected with marek's disease virus |
| 04/28/1997 | CA2185406A1 Improvements in sustainable cell line for the production of marek's disease vaccines |
| 04/24/1997 | WO1997014966A1 Method of activating a novel ligand regulatory pathway |
| 04/24/1997 | WO1997014813A1 A novel human b cell surface molecule |
| 04/24/1997 | WO1997014812A2 Method of screening for factors that modulate gene expression |
| 04/24/1997 | WO1997014809A2 Novel expression vectors and methods of use |
| 04/24/1997 | WO1997014808A2 Herpesvirus vectors and their uses |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014802A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| 04/24/1997 | WO1997014801A1 Novel cell surface protein compounds |
| 04/24/1997 | WO1997014800A1 Novel saliva binding protein |
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014798A2 Polynucleotides and proteins coded thereby useful for controlling melolontha sp. cockchafers |
| 04/24/1997 | WO1997014797A2 Cystatin m, a novel cysteine proteinase inhibitor |
| 04/24/1997 | WO1997014795A1 Tumor associated polypeptides with carboxyl-terminal alanine-proline, proline-proline or glycine-proline and antibodies thereto |
| 04/24/1997 | WO1997014794A1 ACTIVATION OF p53 PROTEIN |
| 04/24/1997 | WO1997014790A1 Cloning of vertebrate pheromone receptors and uses thereof |
| 04/24/1997 | WO1997014789A2 Enzymatic array and process of making same |
| 04/24/1997 | WO1997014782A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/24/1997 | WO1997014717A1 Method of separating albumin from serum by ion-exchange chromatography with membrane adsorbers |
| 04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
| 04/24/1997 | WO1997014715A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014713A1 Amphiphilic complexes, method for preparing same and compositions containing such complexes |
| 04/24/1997 | WO1997014441A1 Method for restoring glucose responsiveness to insulin secretion |
| 04/24/1997 | WO1997014436A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | WO1997014433A1 Chicken interleukin-15 and uses thereof |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997014431A1 Production of recombinant procollagen in yeast |
| 04/24/1997 | WO1997014430A1 Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers |
| 04/24/1997 | WO1997014427A1 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b |
| 04/24/1997 | WO1997014426A1 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014424A1 Neurological drug screens |
| 04/24/1997 | WO1997014416A1 Conjugates useful in the treatment of benign prostatic hyperplasia |
| 04/24/1997 | WO1997014290A1 Synthesis of immunologic, therapeutic and prophylactic compounds by endophytic microorganisms |
| 04/24/1997 | WO1997012044A3 Pichia secretory leader for protein expression |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1997011669A3 MHC-class II restricted melanoma antigens and their use in therapeutic methods |
| 04/24/1997 | WO1997009348A3 Orphan receptor |
| 04/24/1997 | WO1997006258A3 CDNA sequence, amino-acid sequence, derived from the CDNA sequence, of the precursor protein of human GCAP-II/uroguanyline, and amino-acid sequence of the fragment circulating in human blood |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/24/1997 | WO1996034107A3 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/24/1997 | WO1996027665A3 Neuron-restrictive silencer factor proteins |
| 04/24/1997 | DE19642729A1 DNA encoding Bacillus popillae crystal protein |
| 04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 04/24/1997 | DE19538625A1 Verfahren zur Abtrennung von Albumin aus Serum durch Ionenaustauschchromatographie mit Membranadsorbern A process for separating albumin from serum by ion exchange chromatography with membrane adsorbers |
| 04/24/1997 | CA2235278A1 Use of protein s-100b in medicines and medicines containing the protein s-100b |
| 04/24/1997 | CA2235168A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | CA2235075A1 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
| 04/24/1997 | CA2234884A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | CA2234877A1 Herpesvirus vectors and their uses |
| 04/24/1997 | CA2233549A1 Method for restoring glucose responsiveness to insulin secretion |
| 04/24/1997 | CA2232235A1 A novel human b cell surface molecule |
| 04/24/1997 | CA2231582A1 Enzymatic array and process of making same |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769696A2 Antibodies and proteins useful for assaying virus infection in grape plants |
| 04/23/1997 | EP0769559A2 Method for quantifying activated factor VII (FVIIa) |
| 04/23/1997 | EP0769556A1 BARLEY $g(b)-AMYLASE STRUCTURAL GENE |
| 04/23/1997 | EP0769554A2 Human CNP gene and precursor protein |
| 04/23/1997 | EP0769551A1 Dna strand useful in increasing carotenoid yield |
| 04/23/1997 | EP0769149A1 Immunoassay for mycophenolic acid |
| 04/23/1997 | EP0769147A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/23/1997 | EP0769146A2 Screening for nuc inhibitors |
| 04/23/1997 | EP0769144A2 Assay for inhibitors of dp-1 and other dp proteins |